EUCTR2009-013777-17-GB进行中（未招募）1 期
The effect of pamidronate treatment on bone health in patients with neuromuscular disease undergoing hip surgery. - Using pamidronate in patients with CP undergoing hip surgery.
Central Manchester and Manchester University Children's Hospital NHS Trust.0 个研究点目标入组 12 人开始时间: 2010年3月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •All children with neuromuscular conditions between ages 6 and 16 undergoing hip surgery and post-op immobilisation in a hip spica at Royal Manchester Children's Hospital.
- •Exclusion criteria: Failure at screening. Not willing to participate in the study.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effect of pamidronate on bone loss and implant stability after total hip arthroplastyPeriprosthetic bone loss after total hip replacementMusculoskeletal DiseasesPeriprosthetic bone lossISRCTN37786144Arthritis Research Campaign (ARC) (UK)
已完成
4 期
Effect of bisphosphonate on osteoporosis in kidney transplant patientskidney transplant patients with low bone mineral density.Kidney transplant statusIRCT138804162109N1Ahvaz Jundishapur University of Medical Sciences40
已完成
不适用
Efficacy of pamidronate for adult osteogenesis imperfecta: uncontrolled study.Osteogenesis imperfectaJPRN-UMIN000031290Kobe University Hospital10
已完成
4 期
A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.Bone LossNCT00738257Novartis Pharmaceuticals126
已完成
2 期
Effect of Pamidronate on treatment of bone painsCondition 1: Bone pains in Cancer patients with bone metastases. Condition 2: Hypercalcemia in Cancer patients with bone metastases. Condition 3: Quality of life in Cancer patients with bone metastases.Secondary malignant neoplasm of bone and bone marrowDisorders of calcium metabolismLifestyle-related conditionIRCT2013032212197N5Vice chancellor for research of Tonekabon Islamic Azad University41